JAGX - Financial Reports List - Jaguar Health, Inc. - IntrinsicAlpha

Jaguar Health, Inc. JAGX

Healthcare - Biotechnology - NASDAQ - US

$ 5.935

2.18 %

$ 4 M

Market Cap

-0.04

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	52.57%	-8.18%	-13.51%
Annual Report	FY	10-K	2024-12-31	19.75%	6.80%	10.09%
Quarterly Report	Q3	8-K	2024-09-30	10.49%	-26.69%	17.36%
Quarterly Report	Q2	8-K	2024-06-30	1.68%	21.88%	11.17%
Quarterly Report	Q1	8-K	2024-03-31	19.22%	24.39%	16.56%
Quarterly Report	Q4	8-K	2023-12-31	-29.45%	-24.25%	-14.32%
Annual Report	FY	10-K	2023-12-31	-18.36%	12.97%	0.36%
Quarterly Report	Q3	8-K	2023-09-30	-10.70%	37.88%	11.21%
Quarterly Report	Q2	8-K	2023-06-30	-8.39%	-29.71%	-25.05%
Quarterly Report	Q1	8-K	2023-03-31	-24.88%	32.16%	16.24%

1